Clinical significance of minimal sentinel node involvement and management options

Surgical Oncology Clinics of North America

Volumn 19, Issue 3, 2010, Pages 493-505

  Chagpar, Anees B ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Axillary lymph node dissection; Biopsy; Breast cancer; Sentinel node

Indexed keywords

EOSIN; HEMATOXYLIN;

ACCURACY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; COMORBIDITY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL DECISION MAKING; PARTIAL MASTECTOMY; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; BREAST TUMOR; FEMALE; LYMPH NODE; LYMPHADENECTOMY; PATHOLOGY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 77954146853     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.03.002     Document Type: Review

References (83)

1. Giuliano A.E. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996, 62(2):75-77.
2. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996, 276(22):1818-1822.
3. Neville A.M., Price K.N., Gelber R.D., et al. Axillary node micrometastases and breast cancer. Lancet 1991, 337(8749):1110.
4. Cote R.J., Peterson H.F., Chaiwun B., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999, 354(9182):896-900.
5. Cserni G., Amendoeira I., Apostolikas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 2004, 57(7):695-701.
6. Association of Directors of Anatomic and Surgical Pathology ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol 2001, 25(7):961-963.
7. American Joint Committee on Cancer Breast. AJCC cancer staging handbook 2010, 417-460. Springer-Verlag, New York. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
8. White R.L., Wilke L.G. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004, 70(5):420-424.
9. Reed J., Rosman M., Verbanac K.M., et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009, 208(3):333-340.
10. Tan L.K., Giri D., Hummer A.J., et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 2008, 26(11):1803-1809.
11. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 2004, 91(10):1245-1252.
12. Wasif N., Ye X., Giuliano A.E. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty. Ann Surg Oncol 2009, 16(9):2442-2449.
13. Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002, 347(8):567-575.
14. Vinh-Hung V., Verkooijen H.M., Fioretta G., et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 2009, 27(7):1062-1068.
15. Truong P.T., Vinh-Hung V., Cserni G., et al. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 2008, 44(12):1670-1677.
16. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19(5):1539-1569.
17. Harris J.R., Halpin-Murphy P., McNeese M., et al. Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999, 44(5):989-990.
18. Truong P.T., Jones S.O., Kader H.A., et al. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73(2):357-364.
19. Barranger E., Dubernard G., Fleurence J., et al. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 2005, 92(1):17-22.
20. Peintinger F., Reitsamer R., Stranzl H., et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003, 89(4):648-652.
21. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10(10):1140-1151.
22. Lambert L.A., Ayers G.D., Hwang R.F., et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006, 13(3):310-320.
23. Smidt M.L., Kuster D.M., van der Wilt G.J., et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands?. Ann Surg Oncol 2005, 12(12):1066-1072.
24. Degnim A.C., Reynolds C., Pantvaidya G., et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005, 190(4):543-550.
25. Kocsis L., Svebis M., Boross G., et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 2004, 70(11):1019-1024.
26. Soni N.K., Carmalt H.L., Gillett D.J., et al. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 2005, 31(9):958-964.
27. Specht M.C., Kattan M.W., Gonen M., et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005, 12(8):654-659.
28. Krishnamurthy S., Meric-Bernstam F., Lucci A., et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 2009, 115(7):1555-1562.
29. Kohrt H.E., Olshen R.A., Bermas H.R., et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008, 8:66.
30. Pal A., Provenzano E., Duffy S.W., et al. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008, 95(3):302-309.
31. Barranger E., Coutant C., Flahault A., et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005, 91(2):113-119.
32. Coutant C., Rouzier R., Fondrinier E., et al. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat 2009, 113(3):537-543.
33. Coutant C., Olivier C., Lambaudie E., et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 2009, 27(17):2800-2808.
34. Gur A.S., Unal B., Johnson R., et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 2009, 208(2):229-235.
35. Chagpar AB, Scoggins CR, Martin RC, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 2006, 192(6):882-887.
36. Cserni G., Bianchi S., Vezzosi V., et al. Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients. Am J Surg 2007, 194(3):288-293.
37. Leidenius M.H., Vironen J.H., Riihela M.S., et al. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 2005, 31(1):13-18.
38. Silverstein M.J., Gierson E.D., Waisman J.R., et al. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?. Cancer 1994, 73(3):664-667.
39. Scow J.S., Degnim A.C., Hoskin T.L., et al. Simple prediction models for breast cancer patients with solitary positive sentinel nodes-are they valid?. Breast J 2009, 15(6):610-614.
40. Julian T.B., Blumencranz P., Deck K., et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 2008, 26(20):3338-3345.
41. Chagpar A.B., Blumencranz P., Whitworth P.W., et al. Use pre- and intra-operative data to predict probability of positive non-sentinel lymph nodes [abstract]. Cancer Res 2010, 69(4):513.
42. Mignotte H., Treilleux I., Faure C., et al. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002, 28(6):623-626.
43. Travagli J.P., Atallah D., Mathieu M.C., et al. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 2003, 29(4):403-406.
44. Chagpar A.B., Scoggins C.R., Martin R.C., et al. Predicting patients at low probability of requiring post-mastectomy radiation therapy. Ann Surg Oncol 2006, 14(2):670-677.
45. Unal B., Gur A.S., Beriwal S., et al. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys 2009, 75(4):1035-1040.
46. Inokuchi M., Ninomiya I., Tsugawa K., et al. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer 2003, 89(9):1750-1756.
47. Mullenix P.S., Brown T.A., Meyers M.O., et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am J Surg 2005, 189(5):606-609.
48. Wong S.L., Chao C., Edwards M.J., et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 2001, 182(4):330-334.
49. Schreiber R.H., Pendas S., Ku N.N., et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol 1999, 6(1):95-101.
50. Pendas S., Dauway E., Cox C.E., et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999, 65(6):500-505.
51. McIntosh S.A., Going J.J., Soukop M., et al. Therapeutic implications of the sentinel lymph node in breast cancer. Lancet 1999, 354(9178):570.
52. Ryden L., Chebil G., Sjostrom L., et al. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol 2007, 33(1):33-38.
53. Weaver D.L., Krag D.N., Ashikaga T., et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000, 88(5):1099-1107.
54. Pargaonkar A.S., Beissner R.S., Snyder S., et al. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 2003, 127(6):701-705.
55. Weaver D.L., Le U.P., Dupuis S.L., et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol 2009, 33(11):1583-1589.
56. Stitzenberg K.B., Calvo B.F., Iacocca M.V., et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 2002, 117(5):729-737.
57. Yared M.A., Middleton L.P., Smith T.L., et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 2002, 26(3):377-382.
58. Sakaguchi M., Virmani A., Dudak M.W., et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol 2003, 10(2):117-125.
59. Manzotti M., Dell'Orto P., Maisonneuve P., et al. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001, 95(5):307-312.
60. Gillanders W.E., Mikhitarian K., Hebert R., et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 2004, 239(6):828-837.
61. Cserni G., Bianchi S., Vezzosi V., et al. Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study. Pathol Oncol Res 2007, 13(1):5-14.
62. Calhoun K.E., Hansen N.M., Turner R.R., et al. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 2005, 190(4):588-591.
63. Schrenk P., Konstantiniuk P., Wolfl S., et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005, 92(6):707-713.
64. van Deurzen C.H., van H.R., Hobbelink M.G., et al. Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 2007, 29(6):497-505.
65. Viale G., Maiorano E., Pruneri G., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005, 241(2):319-325.
66. Houvenaeghel G., Nos C., Mignotte H., et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 2006, 24(12):1814-1822.
67. Menes T.S., Tartter P.I., Mizrachi H., et al. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg 2005, 200(3):323-327.
68. Fournier K., Schiller A., Perry R.R., et al. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 2004, 239(6):859-863.
69. Nos C., Harding-MacKean C., Freneaux P., et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003, 90(11):1354-1360.
70. Yu J.C., Hsu G.C., Hsieh C.B., et al. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg 2005, 29(7):813-818.
71. van Iterson V., Leidenius M., Krogerus L., et al. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 2003, 82(1):39-45.
72. Hung W.K., Chan M.C., Mak K.L., et al. Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes. ANZ J Surg 2005, 75(1-2):27-31.
73. Fleming F.J., Kavanagh D., Crotty T.B., et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol 2004, 57(1):73-76.
74. den Bakker M.A., van Weeszenberg A., de Kanter A.Y., et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 2002, 55(12):932-935.
75. Rutledge H., Davis J., Chiu R., et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005, 18(6):762-768.
76. Zgajnar J., Besic N., Podkrajsek M., et al. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes. Eur J Cancer 2005, 41(2):244-248.
77. Gipponi M., Canavese G., Lionetto R., et al. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Eur J Surg Oncol 2006, 32(2):143-147.
78. Fink A.M., Lass H., Hartleb H., et al. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer. Ann Surg Oncol 2008, 15(3):848-853.
79. Chagpar A., Middleton L.P., Sahin A.A., et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005, 103(8):1581-1586.
80. Reynolds C., Mick R., Donohue J.H., et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?. J Clin Oncol 1999, 17(6):1720-1726.
81. Li J., Rudas M., Kemmner W., et al. The location of small tumor deposits in the SLN predicts non-SLN macrometastases in breast cancer patients. Eur J Surg Oncol 2008, 34(8):857-862.
82. Cserni G., Burzykowski T., Vinh-Hung V., et al. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 2004, 34(9):519-524.
83. Houvenaeghel G., Nos C., Giard S., et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009, 35(7):690-695.